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Background The xmd dog develops a cardiomyopathy similar to that seen in Duchenne muscular dystrophy patients. In both the canine and human diseases, ECG abnormalities may precede the development of overt cardiac pathological lesions. The purpose of this study was to determine whether specific cellular electrical abnormalities occur in dystrophic ventricular tissue.
Methods and Results Action potentials were recorded in epicardial tissue strips obtained from normal and xmd dogs. Phase 1 amplitude was increased from 86.8+2.7 mV in normal dogs to 94.3± 1.8 mV in xmd dogs (mean+SEM; P<.05). The 4-aminopyridine-sensitive transient outward potassium current (Ito), as recorded in isolated epicardial myocytes using the whole-cell patch-clamp technique, was reduced in xmd dogs compared with age-matched normal dogs. Cell capacitance also was reduced significantly in xmd compared with normal T he xmd dog is an animal model for Duchenne muscular dystrophy (DMD)1-3 in humans, an X-linked recessive disease affecting 1 in 3000 to 4000 births.4 The mutation responsible for this disease in both humans and dogs occurs in the gene encoding the 427-kD protein dystrophin.2,5-11 Dystrophin is a cytoskeletal protein normally found in smooth, skeletal, and cardiac muscle and in neural tissue.6,9-17 Its absence is associated with progressive muscle necrosis and wasting and eventual death from respiratory or cardiac failure.1,18-24 Dystrophin is localized to the cytoplasmic face of the plasma membrane and forms a complex with four glycoproteins and one 59-kD protein.101425-29 A1-though the function of dystrophin is unclear, it has been hypothesized that it provides a link between the intracellular cytoskeleton and extracellular matrix and that it contributes to stabilization of the complex of associated proteins.2730 Recent studies have shown that the absence of dystrophin results in a deficiency of dystrophinassociated proteins. 26'2730 Whether the absence of dystrophin itself and/or the loss the associated proteins initiates the disease process remains to be determined.
The cardiac pathological features in X-linked muscular dystrophy have become an important consideration in the life expectancy of DMD patients. The absence of dystrophin in human and canine hearts results in progressive myocardial degeneration, fibrosis, and necrosis, evolving in a characteristic pattern throughout the subepicardium and the posterobasal left ventricular free wall, with relative sparing of the subendocardium. 31 Whether the rhythm and conduction disturbances present in dystrophic humans and dogs31 are the direct result of the absence of dystrophin or merely a consequence of the disease-related fibrosis and necrosis is unknown. The observation that electrical abnormalities are present early in the disease process32,33 suggests that a primary electrophysiological defect may predate the development of necrosis. One candidate for such a defect is an alteration in the transient outward potassium current (Ito), given that this current is enriched in the subepicardium and is virtually absent in the endocardium. 34 To determine whether ,to is altered in X-linked muscular dystrophy, we measured I, in epicardial myocytes isolated from normal and from xmd dogs of different ages and correlated changes in Ito with alterations of phase 1 repolarization.
Methods Action Potential Measurements
Golden retriever crosses of either sex obtained from a single colony of reared dogs and ranging in age from 16 weeks to adult were anesthetized with Fatal-Plus (390 mg/mL pentobarbital sodium; Vortech Pharmaceuticals; 86 mg/kg IV). Hearts were removed rapidly via a left thoracotomy and were placed in cold oxygenated (95% 02/5% C02) Tyrode's solution containing (in mmol/L): MgCl 0.7, NaH2PO4 0.9, CaCl2 2.0, NaCl 124, NaHCO3 24, KCl 4, glucose 5. 
Cell Preparation
In all animals, the circumflex coronary artery or a branch of the left anterior descending coronary artery was cannulated and a portion of the left ventricle excised. The cannulated segment was placed in a tissue bath and perfused at a constant flow rate of 18 mL/min with oxygenated solutions maintained at 37°C. The heart tissue initially was perfused with Tyrode's solution. After 10 to 15 minutes, the perfusion was switched to a Ca2`-free solution containing (in mmol/L): NaCl 118, KCl 4.8, MgSO4 1.2, KH2PO4 1.2, glutamine 0.68, glucose 11, NaHCO3 25, pyruvate 5, mannitol 2, taurine 10, pH 7.3. At approximately 3 to 5 minutes, collagenase (type II, Worthington Biochemical Corp; 0.4 mg/mL) and bovine serum albumin (BSA, 0.5 mg/mL; Sigma Chemical Co) were added and the perfusion switched to the recirculating mode for 10 to 15 minutes, depending on the age of the dog. Hearts from younger animals were perfused for the shorter times. Digested tissue was sliced away from the subepicardial area and placed in 10 mL of enzyme solution and swirled. The supernatant was collected, and 10 mL of fresh calcium-free solution with 0.4 mg/mL collagenase and 0.5 mg/mL BSA was added to the slurry and gently bubbled in a water bath maintained at 37°C. Supernatant was collected for six subsequent washes at varying time intervals, depending on subjective evaluation of digestion (cloudiness of supernatant). After final pellet formation, the supernatant was removed and the pellet washed in 10 mL of incubation buffer containing (in mmol/L): NaCl 118, KCl 4.8, MgSO4 1.2, KH2PO4 1.2, glutamine 0.68, glucose 11, NaHCO3 20, HEPES 5, pyruvate 5, taurine 10, CaCl2 0.5, and 2% BSA. After 30 minutes of settling, the supernatant was again removed, and the pellet was washed a second time with incubation buffer, now containing 1 mmol/L CaCl2, and allowed to equilibrate at room temperature for 30 minutes. The cells selected for study from either group were rod shaped and quiescent and had clearly demarcated myofibrils. holding potential of -80 mV. The duration of the depolarizing pulses was 300 milliseconds, and the amplitude of 'to was measured as the difference between peak outward current and minimum current during the depolarizing pulse after the peak. By recordings at 22°C to 25°C, the peak outward current was easily distinguished from the capacitative current, and there was little contribution of IK to the steady-state current. To identify the 4-AP-sensitive current, 2 to 20 mmol/L 4-AP was added in one to four experiments from each group.
The decay of Ito was analyzed by a single exponential fit of the current recorded at +40 mV. The voltage dependence of steady-state inactivation was determined by a double-pulse protocol, whereby a 500-millisecond conditioning pulse, ranging from -80 to +40 mV, was followed by a 300-millisecond test pulse to +40 mV. The results were fitted to a Boltzmann function,39 I/Ima,x= 1/1 +exp[(V1/2-Vm)/k] by a least-squares method of nonlinear regression analysis. V1/2 is the membrane potential at which half-inactivation occurs, and k is the slope factor at Vm=V1/2. Recovery from inactivation was examined with a double-pulse protocol, in which the time interval between two 300-millisecond pulses to +40 mV from a holding potential of -80 mV was varied between 5 and 800 milliseconds. Cell capacitance was measured by integration of the area beneath the capacitative transient elicited by 10 mV depolarizing or hyperpolarizing steps and division of that area by the change in voltage. All current measurements were obtained from myocytes isolated from the subepicardium, hereafter referred to as epicardial myocytes.
The hearts from adult xmd dogs show marked degeneration, fibrosis, and calcification.17'31 To separate electrical abnormalities that resulted primarily from the absence of dystrophin per se from those that might have resulted from necrosis and progressive fibrosis, membrane currents and action potentials were recorded in young dogs ranging in age from 16 to 35 weeks that were relatively free of overt disease'7 and clinical signs of heart failure33 and in adult dogs ranging in age from 45 weeks to >1 year. We have shown previously40, that Ito increases with age from 10 weeks to adult and that current density increases from 10 to 20 weeks and remains constant thereafter. In addition, the time constant of current decay increases with age, whereas the kinetics of steady-state inactivation and recovery from inactivation do not change with age. Accordingly, the measurements of current magnitude, current decay, cell capacitance, and cell size were compared at both ages for normal and xmd dogs to eliminate age-related differences in these parameters. The results for the age-independent parameters were combined for all age groups, and comparisons were made between normal and xmd dogs. Because of the X-linked inheritance of the disease, truly unaffected dogs are rarely produced by this colony. Consequently, no normal adult dogs (45 weeks to >1 year of age) were available for this study.
Statistical Analysis
Data are reported as mean±SEM except as noted. Statistically significant differences between groups were evaluated by 500 pAl 20 ms Normal xmd ANOVA (STATVIEW, Abacus Concepts) followed by Scheff6's F test. P<.05 was considered statistically significant.
Results Action Potential Characteristics
The steady-state action potential characteristics of normal and dystrophic cells during superfusion with propranolol (1 ,umol/L) are summarized in Table 1 . The pacing cycle length was 500 milliseconds. Action potentials recorded in normal and xmd dogs were similar with respect to rate of rise (dV/dtmax), APA, RMP, and APD50 and APD90. PhiA was significantly greater inxmd dogs than in normal dogs (Fig 1) .
To demonstrate the sensitivity of PhlA to blockade of It,, the effects of 4-AP (2 mmol/L) were determined. To determine whether the increase of PhlA in dystrophic epicardium reflected a reduction in Ito, the 4-AP-sensitive component of Io was measured in normal and dystrophic myocytes. This current initially was identified by subtracting the currents obtained before and after exposure to 4-AP (Fig 3) . Because the magnitude of the 4-AP-sensitive current was similar to estimates of It, obtained by measuring the difference between the peak and steady-state current during the clamp step, as described above, the latter measurements were used for comparing I,, between groups.
The activation threshold for 1,, was similar in both dystrophic and normal myocytes, at -25 to -30 mV, but the magnitude of Ito in dystrophic myocytes was reduced compared with normal myocytes throughout the cur- not differ between normal and xmd myocytes, averaging 26.1±1.6 and 26.4±1.5 milliseconds, respectively.
The voltage dependence of steady-state inactivation was described by a Boltzmann function. 39 The inactivation of 'to normalized to maximum current followed a sigmoidal shape in both normal and xmd myocytes, with inactivation complete at 0 mV and almost completely removed at membrane potentials more negative than -65 mV and -75 mV for normal and xmd cells, respectively (Fig 7) . V1!2 did not differ between dystrophic and normal myocytes, whereas k was slightly but statistically significantly greater for the dystrophic myocytes (Table 2) .
Recovery from inactivation for 1,. was best fit with a biexponential function, as illustrated in Fig 8, in which the fraction of current that was activated during the second pulse of a double-pulse protocol is shown as a function of the interpulse interval. The r of both the rapid and slow phases of recovery did not differ between normal and xmd myocytes ( 
